The Meaningful Use 3 Rule

By AHRMM

A short introduction to the CMS Meaningful Use 3 Rule and how implementing UDI within the healthcare setting and moving toward the full GS1 will reduce costs and improve inventory management while providing accurate data reporting and complete patient EHR information. Ultimately, these changes will lead to knowledge-based decision making and improved quality of patient care.

Related Resources

Letter/Comment
Recent Guidance on Meaningful Use of EHRs Makes Compliance More Difficult
Recent Guidance on Meaningful Use of EHRs Makes Compliance More Difficult.
Letter/Comment
AHRMM Comment Letter to FDA Regarding the Draft Guidance for Industry on the Global Unique Device Identification Database (GUDID)
On November 21, 2013, AHRMM submitted electronically
Letter/Comment
AHRMM Statement on Comparative Effectiveness
AHRMM supports the concept and use of Comparative Effectiveness Research (CER) to provide evidence-based data to help inform purchasing decis
Issue Brief
Medical Device Excise Tax - What You Should Know
The Medical Device Excise Tax, a component of the Affordable Care Act, is approaching implementation at the beginning of 2013.
Letter/Comment
The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Fo
Advisory
Medical Device Tax Next Steps
The medical device excise tax is a feature of the Affordable Care Act. It is important to be knowledgeable about the tax and its effects.